Steven A Rosenberg
Steven A Rosenberg
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology
VT DeVita, TS Lawrence, SA Rosenberg
Lippincott Williams & Wilkins, 2008
Cancer regression in patients after transfer of genetically engineered lymphocytes
RA Morgan, ME Dudley, JR Wunderlich, MS Hughes, JC Yang, ...
Science 314 (5796), 126-129, 2006
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg, JC Yang, NP Restifo
Nature medicine 10 (9), 909-915, 2004
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley, JR Wunderlich, PF Robbins, JC Yang, P Hwu, ...
Science 298 (5594), 850-854, 2002
A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone
SA Rosenberg, MT Lotze, LM Muul, AE Chang, FP Avis, S Leitman, ...
New England Journal of Medicine 316 (15), 889-897, 1987
A randomized trial of bevacizumab, an anti–vascular endothelial growth factor antibody, for metastatic renal cancer
JC Yang, L Haworth, RM Sherry, P Hwu, DJ Schwartzentruber, ...
New England Journal of Medicine 349 (5), 427-434, 2003
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer
SA Rosenberg, MT Lotze, LM Muul, S Leitman, AE Chang, ...
New England journal of medicine 313 (23), 1485-1492, 1985
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
DW Lee, JN Kochenderfer, M Stetler-Stevenson, YK Cui, C Delbrook, ...
The Lancet 385 (9967), 517-528, 2015
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.
SA Rosenberg, BS Packard, PM Aebersold, D Solomon, SL Topalian, ...
The New England journal of medicine 319 (25), 1676-1680, 1988
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2
RA Morgan, JC Yang, M Kitano, ME Dudley, CM Laurencot, ...
Molecular therapy 18 (4), 843-851, 2010
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy
SA Rosenberg, JC Yang, RM Sherry, US Kammula, MS Hughes, ...
Clinical cancer research 17 (13), 4550-4557, 2011
Adoptive cell transfer as personalized immunotherapy for human cancer
SA Rosenberg, NP Restifo
Science 348 (6230), 62-68, 2015
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes
SA Rosenberg, P Spiess, R Lafreniere
Science 233 (4770), 1318-1321, 1986
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993
MB Atkins, MT Lotze, JP Dutcher, RI Fisher, G Weiss, K Margolin, ...
Journal of clinical oncology 17 (7), 2105-2105, 1999
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer
E Tran, S Turcotte, A Gros, PF Robbins, YC Lu, ME Dudley, ...
Science 344 (6184), 641-645, 2014
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
SA Rosenberg, JC Yang, DJ Schwartzentruber, P Hwu, FM Marincola, ...
Nature medicine 4 (3), 321-327, 1998
T lymphocyte-directed gene therapy for ADA− SCID: initial trial results after 4 years
RM Blaese, KW Culver, AD Miller, CS Carter, T Fleisher, M Clerici, ...
Science 270 (5235), 475-480, 1995
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley, JR Wunderlich, JC Yang, RM Sherry, SL Topalian, NP Restifo, ...
Journal of clinical oncology 23 (10), 2346-2357, 2005
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
SA Rosenberg, NP Restifo, JC Yang, RA Morgan, ME Dudley
Nature Reviews Cancer 8 (4), 299-308, 2008
Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired
M Ahmadzadeh, LA Johnson, B Heemskerk, JR Wunderlich, ME Dudley, ...
Blood, The Journal of the American Society of Hematology 114 (8), 1537-1544, 2009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20